<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">World J Surg Oncol</journal-id>
      <journal-title>World Journal of Surgical Oncology</journal-title>
      <issn pub-type="epub">1477-7819</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18976464</article-id>
      <article-id pub-id-type="pmc">2644689</article-id>
      <article-id pub-id-type="publisher-id">1477-7819-6-115</article-id>
      <article-id pub-id-type="doi">10.1186/1477-7819-6-115</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Giant retroperitoneal liposarcoma</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Herrera-G&#xF3;mez</surname>
            <given-names>&#xC1;ngel</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>herrera_incan@hotmail.com</email>
        </contrib>
        <contrib id="A2" corresp="yes" contrib-type="author">
          <name>
            <surname>Ortega-Guti&#xE9;rrez</surname>
            <given-names>C&#xE9;sar</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>docesar23@hotmail.com</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Betancourt</surname>
            <given-names>Alejandro Mohar</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>amohar@incan.edu.mx</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Luna-Ortiz</surname>
            <given-names>Kuauhyama</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>kuauhyama@starmedia.com</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Surgical Oncology, Instituto Nacional de Cancerolog&#xED;a, M&#xE9;xico, D.F., Mexico</aff>
      <aff id="I2"><label>2</label>Department of Pathology, Instituto Nacional de Cancerolog&#xED;a, M&#xE9;xico, D.F., Mexico</aff>
      <pub-date pub-type="collection">
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>10</month>
        <year>2008</year>
      </pub-date>
      <volume>6</volume>
      <fpage>115</fpage>
      <lpage>115</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.wjso.com/content/6/1/115"/>
      <history>
        <date date-type="received">
          <day>6</day>
          <month>6</month>
          <year>2008</year>
        </date>
        <date date-type="accepted">
          <day>31</day>
          <month>10</month>
          <year>2008</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2008 Herrera-G&#xF3;mez et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Herrera-G&#xF3;mez et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Herrera-G&#x000f3;mez
               &#x000c1;ngel
               
               herrera_incan@hotmail.com
            </dc:author><dc:title>
            Giant retroperitoneal liposarcoma
         </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>World Journal of Surgical Oncology 6(1): 115-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1477-7819(2008)6:1&#x0003c;115&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1477-7819</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Liposarcoma is the most frequent histopathological variety of the retroperitoneum, surgery is the gold standard for treatment.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We present the case of a 24-year-old male who was diagnosed with a giant retroperitoneal liposarcoma. The patient received palliative treatment due to non-resectability on the basis of chemotherapy. We decided to perform surgery after no benefit was received with systemic treatment. Complete macroscopic resection of the tumor was performed, without multi-organ resection. The patient is currently alive and disease free at 14 months of evolution.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Retroperitoneal liposarcomas represent a unique situation and require a more aggressive surgical approach including multiple resections for recurrences. Based on the ability of the patient to tolerate the procedure, surgery is suggested to evaluate resectability of the tumor. We must take into consideration whether prolonged survival will be attained and tumor removal will result in palliation of symptoms.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Liposarcomas are neoplasms of mesodermic origin derived from adipose tissue and correspond to 10&#x2013;14% of all soft tissue sarcomas. They represent &lt; 1% of all malignant tumors [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>The most frequent subtypes are liposarcoma (41%), leiomyosarcoma (28%), malignant fibrous histiocytoma (7%), fibrosarcoma (6%) and tumors of the peripheral nerve sheath (3%) [<xref ref-type="bibr" rid="B3">3</xref>]. Retroperitoneal liposarcomas alone comprise 0.07&#x2013;0.2% of all neoplasias<sup>4</sup>. Approximately 85% of these are malignant, with soft-tissue sarcomas representing 35% of this group. Liposarcoma is the most frequent histopathological variety of the retroperitoneum [<xref ref-type="bibr" rid="B2">2</xref>]. It presents with inherent characteristics in relation to its deep localization and slow expansive growth. Average diameter of the tumor is 20&#x2013;25 cm with a weight of 15&#x2013;20 kg [<xref ref-type="bibr" rid="B4">4</xref>]. There is compromise of the adjacent organs in up to 80% of the cases [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Surgery is the gold standard for treatment of liposarcoma. Retroperitoneal liposarcoma is a distinct clinical entity that requires a more aggressive surgical approach, including multiple resections or multiorgan resection with recurrences. There is a low incidence of distance metastasis (7%) compared to other histological subtypes that range from 15 to 34% [<xref ref-type="bibr" rid="B6">6</xref>]. The objective of this study is to report a case of giant retroperitoneal sarcoma.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 24-year-old male presented with a 6-month evolution of his disease with abdominal pain, constipation, fever and a 20-kg weight loss. He received treatment for typhoid fever without improvement. For this reason, abdominal tomography was performed, demonstrating a heterogeneous lesion with zones of fat and solid density that entirely occupied the abdominal cavity, displacing retroperitoneal structures dorsally. CT-guided biopsy was performed at a different hospital and pathological report demonstrated liposarcoma. Colonoscopy was performed, demonstrating extrinsic compression at the level of the descending colon. The patient was sent to our Institution for further evaluation. Upon admission, the patient had a Karnofsky score of 90 and was classified as grade zero according to the status of the Eastern Cooperative Oncology Group (ECOG). He also presented with respiratory difficulty and distended abdomen due to solid, multilobulated tumor that extended from the epigastrium to the pelvic region without delineated borders. CT scan confirmed previous findings (Fig. <xref ref-type="fig" rid="F1">1</xref>). Histopathological review from the referring hospital demonstrated minute fragments of mature adipose tissue without atypia. This material was considered to be inadequate for diagnosis. For this reason, a new CT-guided biopsy was performed and a well-differentiated sclerosing-type liposarcoma was reported (Fig. <xref ref-type="fig" rid="F2">2</xref>). Because the patient's tumor had previously been considered nonresectable, he was referred to medical oncology where chemotherapy with ifosfamide and adriamycin was offered. Clinical and radiological responses were evaluated and reported stable disease. The patient completed six cycles of adriamycin and ifosfamide and was re-evaluated upon treatment completion. The patient continued with stable disease (no change in tumor size was documented either clinically or radiologically) without change in functional status according to Karnofsky index upon admission. At the conclusion of chemotherapy, supportive therapy vs. chemotherapy with etoposide and ifosfamide was proposed and the patient elected supportive therapy. An interdepartmental meeting was held and, in a joint decision with the patient, surgical exploration was decided upon. Surgery was performed with the patient in dorsal decubitus and a midline incision was made from the xyphoid to the pubis, revealing an 80 &#xD7; 60-cm tumor that encompassed the entire retroperitoneal cavity, with lax adhesions to the descending colon and ureters, neovascularization and adherence to the bladder without multiorgan resection and with macroscopic free margins (Fig. <xref ref-type="fig" rid="F3">3</xref>). Complete resection of the tumor was performed. The patient had a satisfactory evolution and was discharged 48 h postsurgery without adjuvant treatment. The final histopathological report showed undifferentiated liposarcoma of the retroperitoneum (80 &#xD7; 50 &#xD7; 35 cm) weighing 18 kg.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>CT scan. Heterogeneous lesion is observed with zones of fat and solid density that entirely occupy the abdominal cavity, displacing retroperitoneal structures dorsally.</p>
        </caption>
        <graphic xlink:href="1477-7819-6-115-1"/>
      </fig>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>Well-differentiated sclerosing liposarcoma.</p>
        </caption>
        <graphic xlink:href="1477-7819-6-115-2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>Retroperitoneal tumor (80 &#xD7; 60 cm), weighing 18 kg. Complete resection.</p>
        </caption>
        <graphic xlink:href="1477-7819-6-115-3"/>
      </fig>
      <p>The patient is being followed-up every 3 months. At 6 months post-surgery, a new CT scan was done and there was no evidence of disease (Fig. <xref ref-type="fig" rid="F4">4</xref>). Currently, at 14 months of follow-up, the patient is asymptomatic and disease free.</p>
      <fig position="float" id="F4">
        <label>Figure 4</label>
        <caption>
          <p>CT scan. No evidence of tumor activity is demonstrated. Localization of intraabdominal organs is adequate.</p>
        </caption>
        <graphic xlink:href="1477-7819-6-115-4"/>
      </fig>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Liposarcoma is the most frequent histological type of retroperitoneal sarcoma, corresponding to 41% of these tumors [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. It has been reported that 20% of the tumors are &gt; 10 cm at the time of diagnosis [<xref ref-type="bibr" rid="B3">3</xref>]; however, few cases of retroperitoneal liposarcomas exist that can be considered as giant [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B9">9</xref>]. The case we present may be considered among the largest tumors reported for this histology. Clinically, these tumors tend to present with diffuse abdominal pain accompanied by anorexia and weight loss and increase in abdominal girth. The most characteristic sign is a painless abdominal mass detected in ~78% of the cases. Abdominal symptomatology is due to compression of the organs, similar to that reported with the present case [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. It is clear that our patient presented all the signs and symptoms specific for these tumors due to the size of the abdominal mass.</p>
      <p>The tumor was initially considered nonresectable and, therefore, systemic treatment with chemotherapy was decided upon, with the goal of reducing tumor load. Various chemotherapy regimens have been described based on mesna, doxorubicin, ifosfamide, dacarbazine and paclitaxel. However, their use is limited for recurrent metastatic disease or palliation. Survival benefits have not been demonstrated [<xref ref-type="bibr" rid="B10">10</xref>]. Due to the large tumor load and probable multiorgan involvement, we initially considered palliative treatment for our patient. Because the patient did not demonstrate any beneficial effects from chemotherapy, the joint decision of the hospital committee, along with the patient, was to perform surgery. Complete resection of the tumor was performed. We are in agreement with Patrik et al. [<xref ref-type="bibr" rid="B6">6</xref>] who demonstrated that in liposarcomas &gt; 10 cm, complete resection can be carried out in up to 70% of cases; however, in up to 50% of these cases, multiorgan resection is necessary in order to reach this goal [<xref ref-type="bibr" rid="B2">2</xref>]. The most frequent organ resected is the kidney (30%). In the case we report here, even with the large size of the tumor, organ resection was not necessary, because there was no infiltration to neighboring structures, only lax adhesions allowing adequate dissection of the tumor, as shown in Fig. <xref ref-type="fig" rid="F3">3</xref>.</p>
      <p>Radiotherapy (RT) was not considered in this case for two principal reasons: the first was due to the large tumor load and no demonstrable reduction in tumor size and, second, because of the probable gastrointestinal morbidity associated with such an extensive field as in this case. With regard to RT as complementary treatment, there is agreement for its palliative use in non-operable tumors or in cases of incomplete resection [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. Although mesodermic tumors are radioresistant, liposarcoma is more radiosensitive [<xref ref-type="bibr" rid="B6">6</xref>]. Although it has been noted that RT may increase survival and disease-free interval [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>], other authors reported that this treatment has not demonstrated long-term improvement in survival or specific disease in cases of complete macroscopic resections [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. This occurs despite using intraoperative RT with the goal of increasing efficacy of the local dose with 50&#x2013;60 Gy [<xref ref-type="bibr" rid="B7">7</xref>] and of minimizing toxicity to adjacent organs. In our case, because we were dealing with a well-differentiated primary liposarcoma that allowed complete resection, 5-year survival of 75&#x2013;100% [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B11">11</xref>] has been described. Local failure occurs within 5 to 10 years after resection in up to 90% of the cases related to size of tumor, inability to achieve free margins and limitations of adjuvant treatment such as chemotherapy or RT [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. We cannot compare these data with our report because our patient is disease free at 14 months of follow-up.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>Retroperitoneal liposarcomas are a unique situation and require a more aggressive surgical approach including, when necessary, multiorgan resection or multiple resections with recurrences. In accordance with the ability of the patient to tolerate the procedure, surgery is suggested to evaluate tumor resectability, taking into consideration prolonged survival. After tumor removal, palliation of symptoms will be accomplished.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>AHG Carried out the surgery procedure, review the manuscript. COG Carried out the surgery and search for literature review and review manuscript. AMB was the pathologist for this case and review the article. KLO Carried out the surgery, write the article, analysis of the literature and review the article. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this case report.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kilkenny</surname>
              <given-names>JW</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Bland</surname>
              <given-names>KI</given-names>
            </name>
            <name>
              <surname>Copeland</surname>
              <given-names>EM</given-names>
              <suffix>3rd</suffix>
            </name>
          </person-group>
          <article-title>Retroperitoneal Sarcoma. The University of Florida Experience</article-title>
          <source>J Am Coll Surg</source>
          <year>1996</year>
          <volume>182</volume>
          <fpage>329</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="pmid">8605556</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hassan</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>SZ</given-names>
            </name>
            <name>
              <surname>Donohue</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Nagorney</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Nasciemento</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Schleck</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Ilstrup</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Operative management of primary retroperitoneal sarcomas. A reappraisal of an institute experience</article-title>
          <source>Ann Surg</source>
          <year>2004</year>
          <volume>239</volume>
          <fpage>244</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">14745333</pub-id>
          <pub-id pub-id-type="doi">10.1097/01.sla.0000108670.31446.54</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lewis</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Woodruff</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution</article-title>
          <source>Ann Surg</source>
          <year>1998</year>
          <volume>228</volume>
          <fpage>355</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">9742918</pub-id>
          <pub-id pub-id-type="doi">10.1097/00000658-199809000-00008</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Echenique-Elizondo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Amodarain-Arratibel</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Liposarcoma retroperitoneal gigante</article-title>
          <source>Cir Esp</source>
          <year>2005</year>
          <volume>77</volume>
          <fpage>293</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">16420937</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jaques</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Coit</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Hajdu</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Bennan</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum</article-title>
          <source>Ann Surg</source>
          <year>1990</year>
          <volume>212</volume>
          <fpage>51</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">2363604</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McGrath</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Neifeld</surname>
              <given-names/>
            </name>
            <name>
              <surname>Lawrence</surname>
              <given-names>W</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>DeMay</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Horsley</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Improved survival following complete excision of retroperitoneal sarcomas</article-title>
          <source>Ann Surg</source>
          <year>1984</year>
          <volume>200</volume>
          <fpage>200</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">6465975</pub-id>
          <pub-id pub-id-type="doi">10.1097/00000658-198408000-00014</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azpiazu Arnaiz</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Muro Bidaurre</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>De Frutos Gomero</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Castro Esnal</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Martin Lopez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Asesnsio Gallego</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Rivera Garbayo</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Tumores retroperitoneales. Liposarcoma mixoide retroperitoneal. Presentaci&#xF3;n de un nuevo caso</article-title>
          <source>Arch Esp de Urol</source>
          <year>2000</year>
          <volume>53</volume>
          <fpage>170</fpage>
          <lpage>3</lpage>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Romero P&#xE9;rez</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rafie Mazketli</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Amat Cecilia</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Merenciano Cortina</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Gonzalez Devesa</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Tumores adiposos retroperitoneales. A prop&#xF3;sito de un liposarcoma mixoide gigante</article-title>
          <source>Actas Urol Esp</source>
          <year>1996</year>
          <volume>20</volume>
          <fpage>79</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="pmid">8721005</pub-id>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guzman Martinez-Valls</surname>
              <given-names>Pl</given-names>
            </name>
            <name>
              <surname>Ferrero Doria</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>L&#xF3;pez Alba</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tomas Ros</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rodenas Moncfada</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Rico Galiano</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez de Ledesma Vega</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Fontana Compiano</surname>
              <given-names>LO</given-names>
            </name>
          </person-group>
          <article-title>Liposarcoma retroperitoneal. A prop&#xF3;sito de tres casos</article-title>
          <source>Arch Esp de Urol</source>
          <year>1997</year>
          <volume>50</volume>
          <fpage>529</fpage>
          <lpage>31</lpage>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshida</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohsaco</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nagamoto</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tsuruzoe</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Weekly paclitaxel therapy is curative for patients with retroperitoneal liposarcoma</article-title>
          <source>Gan To Kagaku Ryoho</source>
          <year>2007</year>
          <volume>34</volume>
          <fpage>465</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">17353645</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mehrotra</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Ramachandran</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Goel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Arora</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Inflammatory variant of a well-differentiated retroperitoneal liposarcoma: case report of a rare giant variety</article-title>
          <source>Indian J Cancer</source>
          <year>2006</year>
          <volume>43</volume>
          <fpage>36</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">16763361</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
